Sandu Pharmaceuticals Limited (BOM:524703)

Market Cap	338.33M -33.9%
Revenue (ttm)	671.50M -2.3%
Net Income	20.52M +13.0%
EPS	2.11 +12.2%
Shares Out	9.66M
PE Ratio	16.60
Forward PE	n/a
Dividend	0.80 (2.28%)
Ex-Dividend Date	Sep 18, 2025

Volume	1,111
Average Volume	4,611
Open	34.66
Previous Close	35.05
Day's Range	34.50 - 37.45
52-Week Range	30.55 - 58.80
Beta	-0.08
RSI	46.71
Earnings Date	Feb 6, 2026

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasav...

• Industry: Pharmaceutical Preparations
• Founded: 1899
• Employees: 303
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524703

Financial Performance

In fiscal year 2025, Sandu Pharmaceuticals's revenue was 671.92 million, a decrease of -0.13% compared to the previous year's 672.81 million. Earnings were 15.52 million, an increase of 6.19%.